Astrotech Corporation Reports 43% Revenue Decline in Q2 Fiscal 2026

Astrotech Corporation reported a decline in financial performance for the second quarter of fiscal year 2026, ending December 31, 2025. The company generated revenue of $148,000, a decrease of 43% compared to $261,000 in the same quarter of the previous year. For the six-month period, revenue increased to $445,000 from $295,000, primarily driven by a rise in grant revenue and consumables. However, the overall gross profit for the quarter was $8,000, down from $155,000 a year earlier, reflecting a gross margin of 5%, a significant drop from 59% in the prior year.

Operating expenses decreased by 12.7% to $3.9 million for the quarter, compared to $4.5 million in the same period last year. This reduction was attributed to lower research and development costs, which fell by 24.8% due to decreased spending on materials and consulting. Despite the decrease in operating expenses, the company reported a net loss of $3.9 million for the quarter, slightly improved from a loss of $4.0 million in the prior year. For the six-month period, the net loss was $7.4 million, compared to $7.3 million in the same period last year.

Astrotech's operational developments included the introduction of new products and the expansion of its customer base. The company has been focusing on its subsidiaries, particularly 1st Detect Corporation, which has developed the TRACER 1000, a mass spectrometer-based explosives trace detector. As of December 31, 2025, the TRACER 1000 was deployed in approximately 35 locations across 16 countries. The company also reported an increase in consumables revenue, although it was not sufficient to offset declines in other product categories.

The company’s balance sheet showed total assets of $19.7 million as of December 31, 2025, down from $27.0 million at the end of the previous fiscal year. Cash and cash equivalents remained stable at approximately $3.1 million. Astrotech's working capital was reported at $12.5 million, a decrease from $25.5 million a year earlier. The company continues to face challenges related to customer concentration, with a few customers accounting for a significant portion of its revenue.

Looking ahead, Astrotech management expressed optimism about its ability to fund planned expenditures over the next 12 months, although they acknowledged the potential need for additional resources to execute business plans. The company is actively pursuing opportunities to expand its market presence and product offerings, particularly in the mass spectrometry and gas chromatography sectors. However, management also noted the risks associated with market conditions, competition, and the regulatory environment, which could impact future performance.